Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Humantech Biotech, officially Wuhan Humantech Biotech Co., Ltd., is a prominent medical diagnostics company headquartered in Wuhan, China. Established in 2015, the firm specializes in the research, development, and manufacturing of in vitro diagnostic (IVD) reagents and automated testing instruments. Its core business focuses on Point-of-Care Testing (POCT) platforms that utilize immunofluorescence, colloidal gold, and chemiluminescence technologies. The company’s product menu covers a wide array of clinical areas, including cardiovascular disease, inflammation markers, gastric function, and infectious diseases such as COVID-19. Humantech Biotech integrates research, manufacturing, and global distribution to provide rapid diagnostic results for hospitals and primary care facilities. The company is recognized for its high-throughput automated analyzers and specialized reagent kits that support early disease detection and management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Humantech Biotech.